Statistical studies of N-glycosylated proteins have indicated that the frequency of nonglycosylated Asn-Xaa-(Thr/Ser) sequons increases toward the C terminus (Gavel, Y., and von Heijne, G. (1990) Protein Eng. 3, 433-442). Using in vitro transcription/translation of a truncated model protein in the presence of dog pancreas microsomes, we find that glycosylation efficiency of Asn-Xaa-Thr sequons indeed is reduced when the sequon is within ϳ60 residues of the C terminus. Surprisingly, the presence of a hydrophobic stop transfer sequence between the Asn-Xaa-Thr sequon and the C terminus results in a very different dependence of glycosylation efficiency on the distance to the C terminus, where the presence of the stop transfer segment inside the ribosome appears to cause a drastic drop in the level of glycosylation. We speculate that this may reflect a change in the structure of the ribosome/translocon complex induced by the stop transfer segment.
In mammalian cells, nascent secretory and membrane proteins are co-translationally glycosylated on Asn-Xaa-(Thr/Ser) sequons by the endoplasmic reticulum (ER) 1 enzyme oligosaccharyl transferase (OST) (1) . The OST complex is associated with the Sec61 translocon, through which proteins are translocated into the lumen of the ER or inserted into the ER membrane (2) . A highly regulated mechanism has been observed during synthesis of transmembrane proteins, where the emergence of a hydrophobic stop transfer (ST) sequence inside the ribosome triggers the closing of the lumenal end of the translocon pore and the almost simultaneous opening of the cytosolic ribosome/translocon seal (3, 4) . Structural changes on both sides of the translocon are thus effected by the ST sequence from inside the ribosome, but whether these changes are also transmitted to the OST or otherwise influence the glycosylation reaction is unknown.
Previously, we have found that the lumenally oriented active site of the OST is positioned at a well defined distance from the surface of the ER membrane (5) and can be used as a fixed point of reference to study structural changes in transmembrane segments in the ER membrane (6, 7) . Here, we have measured the efficiency of N-glycosylation of Asn-Xaa-Thr sequons as a function of their distance from the C-terminal end of a model protein, in both the absence and the presence of an intervening hydrophobic ST sequence. When there is no ST sequence between the glycosylation acceptor sequon and the C terminus, the glycosylation efficiency increases as the stop codon is moved further away from the sequon and plateaus at a distance of ϳ60 residues or more. In stark contrast, with poly-Leu ST sequences of either 15 or 30 hydrophobic residues placed between the acceptor sequon and the C terminus, we observe a dramatic drop in glycosylation efficiency when the C-terminal end of the protein is located immediately downstream of the transmembrane segment. This effect persists until the N-terminal end of the ST sequence is 40 -50 residues away from the C-terminal residue, suggesting that the presence of a hydrophobic stretch inside the ribosome when translation terminates somehow prevents access to the OST of a glycosylation acceptor site located immediately upstream of the hydrophobic segment. We speculate that this finding may be related to the previously observed closing of the lumenal end of the translocation channel induced by the appearance of a hydrophobic segment inside the ribosome (3).
MATERIALS AND METHODS
Enzymes and Chemicals-Unless otherwise stated, all enzymes as well as plasmid pGEM1, RiboMAX SP6 RNA polymerase system, and rabbit reticulocyte lysate were from Promega (Madison, WI). Taq polymerase, T7 DNA polymerase, [ 35 S]Met, 14 C-methylated protein standards, deoxyribonucleotides, dideoxyribonucleotides, and the cap analog m7G(5Ј)ppp(5Ј)G were from Amersham Pharmacia Biotech. The glycosylation acceptor peptide N-benzoyl-Asn-Leu-Thr-N-methylamide was from Quality Controlled Biochemicals (Hopkinton, MA). The signal peptidase inhibitor N-methoxysuccinyl-Ala-Ala-Pro-Val-chloromethylketone was obtained from Sigma. Oligonucleotides were purchased from Kebo Lab (Stockholm, Sweden) and from Eurosequence (Groningen, the Netherlands). The PCR purification kit and RNeasy RNA clean up were from Qiagen (Hilden, Germany). Oligonucleotides were from Cybergene (Stockholm, Sweden).
DNA Manipulations-Insertion of the stop transfer sequences QQQL 14 VKKKK and QQQL 29 VKKKK into the P2 domain of Lep was performed by introducing BclI and NdeI restriction sites in codon 214 and 220, respectively. Double-stranded oligonucleotides coding for the above amino acid sequences were then cloned between the BclI and NdeI restriction sites. Site-specific mutagenesis of the lepB gene used to make a Asn 214 3 Gln mutation (to remove a potential glycosylation acceptor site), to introduce new Asn-Ser-Thr glycosylation acceptor sites, and to introduce restriction enzyme cleavage sites was performed in phage M13 according to the method of Kunkel (8, 9) .
The Lep-ST29L(CC/50) construct was made by first cloning a PCRamplified fragment from the P2 domain of Lep into the Lep-ST29L construct to obtain Lep-ST29L (50). The 5Ј primer used in the amplification of the Lep fragment had a EcoRV site in codon 150, and the 3Ј primer had a BssHII site in codon 213 in the lepB gene. In a second step, the Lep-ST29L(CC/50) construct was made by ligating PCR-amplified fragments from a previously constructed Lep-derivative with a signal peptidase cleavage cassette inserted at the C-terminal end of a H2 transmembrane segment composed of 14 leucine residues (10) and from the Lep-ST29L (50) construct. The 5Ј primer used for amplification of the cleavage cassette containing Lep fragment was situated 210 bases upstream of the translational start site, and the 3Ј primer had a BglII site in codon 84 in the lepB gene. The 5Ј primer used in the amplification of the Lep-ST29L (50) fragment had a BglII site in codon 88 in the lepB gene. The newly created fusion joint had the amino acid sequence . . . PFQI 86 SS 88 . . . (numbers refer to the wild type Lep sequence). The amplified fragments were ligated in the gel after agarose gel purification, and mRNA templates were prepared by PCR amplification of the ligated fragments using 5Ј and 3Ј primers as described below.
For cloning into and in vitro expression from the pGEM1 plasmid, the 5Ј end of the lepB gene was modified first by the introduction of a XbaI site and second by changing the context 5Ј to the initiator ATG codon to a "Kozak consensus" sequence (11) . Thus, the 5Ј region of the gene was modified to: . . .ATAACCCTCTAGAGCCACCATGGC-GAAT . . . (XbaI site and initiator codon underlined). Mutants of Lep made in phage M13 were cloned into pGEM1 behind the SP6 promoter as a XbaI-SmaI fragment. All mutants were confirmed by DNA sequencing of plasmid and single-stranded M13 DNA using T7 DNA polymerase.
Templates for in vitro transcription of truncated mRNA with a 3Ј stop codon were prepared using PCR to amplify fragments from pGEM1 plasmids containing the relevant Lep constructs. The 5Ј primer was the same for all PCR reactions and had the sequence 5Ј-TTCGTCCAAC-CAAACCGACTC-3Ј. This primer is situated 210 bases upstream of the translational start, and all amplified fragments contained the SP6 transcriptional promoter from pGEM1. The 3Ј primers were designed according to the desired positions of the stop codons. All 3Ј primers contained the tandem translational stop codons TAG TAA and were designed to have approximately the same annealing temperature as the 5Ј primer. PCR amplification was performed with a total of 30 cycles using an annealing temperature of 52°C. The amplified DNA products were purified using the Qiagen PCR purification kit as described in the manufacturer's protocol and verified on a 1.2% agarose gel.
In Vitro Transcription-Truncated mRNAs with stop codons were transcribed from the SP6 promoter using the RiboMAX SP6 RNA polymerase system. Transcriptions were carried out at 30°C for 12 h. The mRNAs were purified using Qiagen RNeasy clean up kit and verified on a 1.2% agarose gel.
In Vitro Translation-Translation in reticulocyte lysate in the presence of dog pancreas microsomes was performed as described in Ref. 12 , and alkaline extraction was performed as described in Ref. 13 . Proteins were analyzed by SDS-polyacrylamide gel electrophoresis, and gels were quantitated on a Fuji BAS1000 phosphoimager using the MacBAS 2.31 software. The extent of glycosylation of a given mutant was calculated as the quotient between the intensity of the glycosylated band divided by the summed intensities of the glycosylated and nonglycosylated bands. For some constructs, the assay was repeated in the presence of a glycosylation acceptor tripeptide as described (5) or in the presence of a signal peptidase inhibitor (14) .
RESULTS
We used the well characterized Escherichia coli inner membrane protein leader peptidase (Lep) (Fig. 1A) to measure the glycosylation efficiency of Asn-Xaa-Thr sequons in C-terminally truncated proteins. When Lep is expressed in vitro in the presence of dog pancreas microsomes, both the N-terminal tail and C-terminal P2 domain are translocated to the lumenal side, the same orientation as in E. coli (5) . A cryptic glycosylation site in the P2 domain, Asn 214 -Glu-Thr, is efficiently glycosylated upon translocation into the lumen. Fig. 2 , although there is some variation depending on the exact location of the stop codon, the glycosylation efficiency is reduced by more than 50% when the glycosylation acceptor site is very close to the C terminus, and the efficiency increases gradually with the distance between the acceptor site and the C terminus. Full glycosylation, which is 70 -80% in this system (5) , is observed when the distance between the acceptor site and the C terminus is ϳ60 residues or more. For efficient modification, it thus appears that the acceptor site has to reach or at least be close to the OST active site, which is ϳ65 residues away from the ribosomal P-site (15), before chain termination. These results are consistent with an earlier study of the rabies virus glycoprotein, where a reduced glycosylation efficiency of two mutants truncated, respectively, 27 and 69 residues downstream of an acceptor Asn was noted (16) .
Glycosylation Efficiency Increases with the Distance from the C Terminus-To
A Hydrophobic Stop Transfer Sequence between the Acceptor Site and the Stop Codon Affects Glycosylation Efficiency-Because the results reported above indicated that glycosylation efficiency depends on the location of the acceptor site relative to the OST active site at the time of chain termination, we considered the possibility that glycosylation efficiency may also be influenced by the presence of a hydrophobic ST sequence between the acceptor site and the C terminus.
We thus constructed C-terminally truncated versions of two previously studied model proteins (Lep-ST14L and Lep-ST29L) (6) (Fig. 3A) (Fig. 3B) . C-terminal truncations were made by introducing tandem stop codons at different sites downstream of and inside the ST segments, and glycosylation was assayed by in vitro transcription/translation in the absence and presence of microsomes. As shown in Fig. 3C , for both constructs the glycosylation efficiency remains at ϳ35% until the stop codon is placed ϳ10 residues into the hydrophobic stretch and then increases to the level seen without a hydrophobic segment. Strikingly, the glycosylation efficiency drops sharply as soon as the stop codon is placed downstream of the ST segment and remains low until the C terminus of the truncated protein is ϳ70 residues away from the glycosylation site. Thus, the glycosylation efficiency appears to depend both on the position of the C terminus relative to the ST sequence and to the glycosylation acceptor site.
To determine whether the proteins truncated in or near the ST sequence were retained in the membrane, we tested two additional series of constructs. First, we repeated the above experiments using a Lep-ST29L construct with the glycosylation site placed in position 208, only 11 residues upstream of the ST segment. We have shown previously that a glycosylation acceptor site must be at least 13-15 residues upstream of a membrane-anchored ST segment to be a substrate for OST (5, 6) , and indeed, no glycosylation was seen for the Lep-ST29L(Asn 208 -Ser-Thr) construct, Fig. 4 (lane 1) . Similarly, no glycosylation was seen when this construct was truncated by placing tandem stop codons 1, 5, and 15 positions downstream of the ST29L segment (data not shown) or in a position leaving 15 leucine residues in the ST segment (lane 2). However, when only 10 leucines were left in the ST segment, the glycosylation efficiency increased to 20% (lane 3), and with only 5 leucines left, it increased to 38% (lane 4). In the latter construct, the protein was truncated 16 residues downstream of Asn 208 , and the glycosylation efficiency was thus similar to what was found for the short Lep constructs lacking an ST segment (Fig. 2) .
As a second control, we introduced a signal peptidase cleavage cassette (10) at the C-terminal end of the H2 transmembrane segment (Fig. 5A ) and assayed membrane integration of constructs truncated at different positions in the ST segment by alkaline extraction (17) . For this, Lep-ST29L with the acceptor site at Asn 203 was modified by (i) exchanging H2 for a 14-leucine-long hydrophobic segment ending with a signal peptidase cleavage cassette and (ii) adding an extra 50 residues to the P2 domain. The lengthening of the P2 domain was necessary to avoid that the P2-ST fragment remaining after signal peptidase cleavage overlapped in the gel with nonspecific background bands from the in vitro translation. As seen in Fig. 5B , the resulting full-length Lep-ST29L(CC/50) construct was cleaved by signal peptidase and glycosylated when expressed in the presence of rough microsomes. Significantly, as seen in From these two sets of control experiments, we conclude that truncated ST segments retaining ϳ15 leucine residues or more are efficiently anchored in the membrane (presumably in a transmembrane disposition), whereas those with ϳ10 or fewer leucine residues are largely released into the lumen of the microsomes. Thus, the drop in glycosylation efficiency seen in Fig. 3 for proteins truncated after the ST segment cannot be explained by a lack of proper membrane integration of the ST segment.
To rule out that the identity of the codon next to the stop codon had an influence on the results, we made two further controls. First, we changed the valine codon GTT at the end of the ST segment in Lep-ST14L to one (GTG) more frequently used in mammalian mRNAs, and placed a stop codon in the next position. Second, we changed the valine codon to one coding for leucine (CTG), again placing the stop codon in the next position. In neither case did we observe an effect on 1 and 2) in the absence (Ϫ) and presence (ϩ) of dog pancreas rough microsomes (RM). Glycosylated and nonglycosylated products are shown by black and white dots, respectively. B, the glycosylation efficiency of four different Lep constructs with unique glycosylation acceptor sites in position 201 (black dots), 203 (white dots), 214 (light gray dots), and in different positions relative to the C terminus of the full-length protein (dark gray dots) is shown as a function of the number of residues between the acceptor Asn and the C terminus. A rough fit to the experimental points is shown by the gray area. Truncated proteins were made by PCR amplification of the desired part of the gene using a 3Ј primer containing tandem stop codons, followed by in vitro transcription/translation in the presence of dog pancreas microsomes.
glycosylation, which remained at ϳ60% (data not shown). Finally, to rule out the possibility that the low level of glycosylation seen when the stop codon was placed immediately downstream of the ST sequence was caused by the four flanking lysine residues, we changed the C-terminal sequence . . . LVKKKKHM(stop) to . . . LVDPNQHM(stop) for both the ST14L and ST29L constructs; again no change in glycosylation efficiency was seen (data not shown).
DISCUSSION
Statistical studies of the location of glycosylated and nonglycosylated potential acceptor sites in secreted proteins have indicated that the frequency of nonglycosylated Asn-Xaa-(Thr/ Ser) sequons increases toward the C-terminal end of glycoproteins (18) . We now find a similar trend when we successively increase the number of residues between an acceptor site and the C terminus of truncated Lep constructs (Fig. 2) , suggesting that glycosylation is inefficient when chain termination happens before the acceptor site reaches the OST active site. Previous measurements have shown that ϳ65 residues in a nascent polypeptide chain are required to span the distance between the ribosomal P-site and the OST active site (15), and we indeed see fully efficient glycosylation only when ϳ60 residues or more separate the glycosylation acceptor site from the C terminus.
The rate of chain elongation in vitro is quite slow (ϳ1 residue/s (19)), and it is possible that the reduction in glycosylation efficiency seen when chain termination precedes glycosylation is the result of a more rapid translocation of the nascent chain relative to the OST once it has been detached from the ribosome. Although we have not tested the truncated Lep constructs in vivo, the observation that more nonglycosylated Asn- -ST29L (q) constructs as a function of the number of residues between the acceptor Asn and the C terminus. The locations of the 14L and 29L hydrophobic ST segments relative to the glycosylation acceptor site are shown as hatched bars, the C-terminal sequences of a few selected constructs are given, and the relation between glycosylation efficiency and distance to the C terminus from Fig. 2 is indicated by the gray area. Note that the gradation of the x axis is different from that in Fig. 2 .
Xaa-(Thr/Ser) sequons are found near the C-terminal end of secreted glycoproteins (18) suggest that also in vivo chain termination can influence glycosylation efficiency. We also note that the reduction in glycosylation efficiency seen when the glycosylation site is close to the C-terminal end of the protein needs to be taken into account when mapping the topology of integral membrane proteins by glycosylation scanning (14, 20 -22) and points to the necessity to use sufficiently large Cterminal reporter domains.
When a hydrophobic ST sequence is present between the acceptor site and the C terminus, a very different behavior is observed. In particular, for constructs where the C-terminal end of the protein is located in a region immediately downstream of the hydrophobic segment, very low levels of glycosylation are seen (Fig. 3C) , even though the separation between the acceptor site and the C terminus is ϳ50 residues or more. The level of glycosylation returns to "normal" only when the C terminus is ϳ70 residues or more away from the acceptor site, i.e. at a point where the acceptor site has just emerged in the vicinity of the OST active site when the stop codon is reached (15) . The reduction in the glycosylation efficiency thus corresponds to a situation where the ST sequence has been fully polymerized but is still largely inside the ribosome at the time of chain termination.
The dramatic effect on glycosylation caused by the ST sequence suggests that the hydrophobic segment may in some way affect the structure of the ribosome-translocon-OST complex from inside the ribosome. Indeed, recent experiments have shown that the translocon pore is gated during membrane protein integration; whereas the translocon pore is normally open toward the lumen and closed by the ribosome on the cytosolic side during chain translocation, this situation is rapidly reversed when an ST sequence appears inside the ribosome (3, 4) . The conversion to a state open toward the cytosol and closed toward the lumen happens already when 4 -9 residues have been polymerized in addition to the ST sequence. Similarly, the drop in glycosylation efficiency seen in Fig. 3C happens when the stop codon is placed only a couple of residues downstream of the hydrophobic stretch, both for ST14L and for ST29L. We thus speculate that the closing of the lumenal end of the translocon induced by the presence of an ST sequence in the ribosome also affects the way in which the nascent chain is exposed to the OST and thus indirectly the efficiency with which glycosylation acceptor sites near the C-terminal end of the nascent chain are modified.
from signal peptidase cleavage are indicated by arrows, and glycosylated and nonglycosylated products are indicated by black and white dots, respectively. Mw, molecular weight (kDa). 
